Skip to Main Content

Paper Details

Long-term Outcomes of Adding Lutein/Zeaxanthin and Ï¿-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
JAMA Ophthalmol
37
2022
Author NameAffiliation
Emily Y ChewDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Traci E ClemonsThe EMMES Corporation
Elvira Agr??nDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Amitha DomalpallyUniversity of Wisconsin
Tiarnan D L KeenanDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Susan VitaleDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
  • 1 - 6

Datasets

Release 1.2